Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Br J Haematol. 2018 Sep;182(6):870-886. doi: 10.1111/bjh.15456. Epub 2018 Jul 9.
Graft-versus-host disease (GVHD) is a major complication after allogeneic haematopoietic stem cell transplantation (allo-HSCT) that is frequently associated with bone marrow (BM) suppression, and clinical management is challenging. BM endothelial progenitor cells (EPCs) play crucial roles in the regulation of haematopoiesis and thrombopoiesis. However, little is known regarding the functional roles of BM EPCs in acute GVHD (aGVHD) patients. In the current prospective case-control study, reduced and dysfunctional BM EPCs, characterized by decreased migration and angiogenesis capacities and increased levels of reactive oxygen species (ROS) and apoptosis, were found in aGVHD patients compared with those without aGVHD. Moreover, lower frequency and increased levels of ROS, apoptosis and DNA damage, but reduced colony-forming unit-plating efficiency were found in BM CD34 cells of aGVHD patients compared with those without aGVHD. The severity of aGVHD and GVHD-mediated cytopenia was associated with BM EPC impairment in aGVHD patients. In addition, the EPC impairment positively correlated with ROS level. Taken together, our results suggest that reduced and dysfunctional BM EPCs may be involved in the pathogenesis of aGVHD. Although these findings require validation, our data indicate that improvement of BM EPCs may represent a promising therapeutic approach for aGVHD patients.
移植物抗宿主病 (GVHD) 是异基因造血干细胞移植 (allo-HSCT) 后的一种主要并发症,常伴有骨髓 (BM) 抑制,临床管理具有挑战性。BM 内皮祖细胞 (EPCs) 在调节造血和血小板生成中起着至关重要的作用。然而,对于 BM EPCs 在急性移植物抗宿主病 (aGVHD) 患者中的功能作用知之甚少。在当前的前瞻性病例对照研究中,与无 aGVHD 患者相比,aGVHD 患者的 BM EPCs 数量减少且功能失调,表现为迁移和血管生成能力下降,活性氧 (ROS) 和细胞凋亡水平升高。此外,与无 aGVHD 患者相比,aGVHD 患者的 BM CD34 细胞中 ROS、细胞凋亡和 DNA 损伤的频率较低,而 ROS、细胞凋亡和 DNA 损伤的水平较高,集落形成单位-平板效率降低。aGVHD 患者的 aGVHD 严重程度和 GVHD 介导的细胞减少与 BM EPC 损伤有关。此外,EPC 损伤与 ROS 水平呈正相关。总之,我们的研究结果表明,BM EPCs 的减少和功能失调可能与 aGVHD 的发病机制有关。尽管这些发现需要进一步验证,但我们的数据表明,改善 BM EPCs 可能是 aGVHD 患者有希望的治疗方法。